Less prostate cancer screening reduces overdiagnosis but may miss aggressive cases Dr. Kamal Kant Kohli28 April 2022 9:00 AM ISTOver the past 15 years, public health authorities have downgraded recommendations for the prostate-specific antigen (PSA) test as a screening tool to...
Long term insomnia associated with incident Prostate cancer Medical Dialogues Editorial Team26 April 2022 9:00 AM ISTIn a new study conducted by Xiaoyan Lv and and team it was shown that having a relatively easy time getting out of bed in the morning and frequently...
DXA screening may help prevent fractures among older men with prostate cancer: JAMA Dr. Shravani Dali22 April 2022 6:15 AM ISTAndrogen deprivation therapy (ADT) negatively impacts bone health and results in decreased bone mineral density and fractures, finds a new study....
Androgen deprivation therapy in men with prostate cancer reduces risk of thyroid diseases: Study Medha Baranwal18 April 2022 9:00 AM ISTTaiwan: The use of androgen deprivation therapy (ADT) in men with metastatic prostate cancer (PCa) is tied to a reduced risk of thyroid disease...
DXA Scan Can Prevent Major Fractures among Prostate Cancer patients on ADT MD Bureau11 April 2022 9:00 AM ISTProstate cancer accounts for 26% of all new cancers in men. Androgen deprivation therapy (ADT) is the mainstay for the treatment of locally advanced...
Triple drug combo prolongs survival in men with metastatic, hormone-sensitive prostate cancer Hina Zahid2 April 2022 9:00 AM ISTResults from an international, randomized, double-blind, placebo-controlled, phase 3 clinical trial indicate that adding the androgen-receptor...
MRI-guided stereotactic body radiation reduces additional toxicity in prostate cancer: ASCO Medical Dialogues Editorial Team28 March 2022 9:00 AM ISTLos Angeles, CA: A new study demonstrated that MRI-guided prostate stereotactic body radiation (SBRT) results in a statistically significant decrease...
Novartis gets USFDA nod for Pluvicto to treat prostate cancer Ruchika Sharma27 March 2022 10:00 AM ISTBasel: Novartis has recently announced that the US Food and Drug Administration (USFDA) has approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan)...
Darolutamide increases survival in patients with metastatic, hormone-sensitive prostate cancer: NEJM Medha Baranwal12 March 2022 9:00 AM ISTUSA: Findings from a trial showed that the addition of darolutamide to androgen-deprivation therapy, and docetaxel increased overall survival in...
Ultrasound scan may help diagnose prostate cancer Hina Zahid9 March 2022 9:00 AM ISTUltrasound scan can diagnose prostate cancer - An ultrasound scan can be used to detect cases of prostate cancer, according to new...
Family history of prostate cancer tied to increased probability of malignancies Medical Dialogues Editorial Team7 March 2022 9:00 AM ISTUSA: In a new study led by Matthew B. Clements, it was found that men with biopsy indications and a family history of prostate or breast cancer are...
MRI-guided radiotherapy appears to lead to fewer side effects from treatment for prostate cancer Hina Zahid18 Feb 2022 9:00 AM ISTAn interim analysis of an ongoing Phase III study from UCLA Jonsson Comprehensive Cancer Center indicates that using magnetic resonance imaging (MRI)...
